id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1996-P-0002-0001,FDA,FDA-1996-P-0002,Determination That Selegillne Hydrochloride 5-Milligram Tablet Was Not Withdraw From Sale For Reasons of Safety or Effectiveness,Notice,N-Notice,1996-08-21T04:00:00Z,1996,8,1996-08-15T04:00:00Z,,2024-12-11T17:12:43Z,96 20857,0,0,09000064804f98ca
FDA-1996-P-0002-0002,FDA,FDA-1996-P-0002,Acknowledgment letter from FDA DMB to Novopharm Limited,Other,ACK-Acknowledgement Letter,1996-06-12T04:00:00Z,1996,6,,,2024-06-18T17:37:54Z,,0,0,09000064804f98d2